MedPath

Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane. A randomized controlled clinical trial.

Not Applicable
Conditions
intrabony defects
K05.3
Chronic periodontitis
Registration Number
DRKS00005214
Lead Sponsor
niversity of Naples Federico II
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Chronic periodontitis
FMPS = 20 % at baseline
FMBS = 20 % at baseline
Non-contained osseous defect with an intrabony component = 3 mm located in the interproximal area of single-rooted teeth including first maxillary premolars and flat surfaces of molar teeth
Presence of = 2 mm of keratinized tissue

Exclusion Criteria

Relevant medical conditions contraindicating surgical interventions
Pregnancy or lactation
Tobacco smoking
Interproximal intrabony defects extending into the furcation area of molar teeth
Untreated periodontal conditions

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gain in clinical attachment level measured with a graduated probe in mm at tooth sites with non-contained intrabony defects at baseline and after 12 months.
Secondary Outcome Measures
NameTimeMethod
Residual probing pocket depth (PPD) in mm at tooth sites with non-contained intrabony defects after 12 months.
© Copyright 2025. All Rights Reserved by MedPath